Momate
Momate is a medium-potency topical corticosteroid containing Mometasone Furoate. It exhibits anti-inflammatory, antipruritic, and vasoconstrictive properties to reduce swelling, redness, and itching associated with skin conditions. In its nasal spray form, it manages allergic rhinitis symptoms by reducing inflammation in the nasal passages.
Dosage by Body Weight
For topical formulations, apply a thin film to the affected skin areas once daily. Do not use with occlusive dressings unless directed by a physician. For nasal spray, the typical dose is 1 to 2 sprays in each nostril once daily. Topical steroids are not dosed by body weight; pediatric usage requires strict medical supervision to avoid systemic absorption.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy in infants under this weight have not been established; high risk of systemic steroid absorption.
- Body Weight
- 5-7 kg
- Dose
- Not routine
- Frequency
- Use only if prescribed
- Tracking Notes
- Requires pediatric supervision. Apply the smallest effective amount to minimal surface areas for the shortest duration.
- Body Weight
- 8-10 kg
- Dose
- Not routine
- Frequency
- Use only if prescribed
- Tracking Notes
- Avoid prolonged use, application to face, or diaper area under occlusion.
- Body Weight
- 11-15 kg
- Dose
- Not routine
- Frequency
- Once daily if prescribed
- Tracking Notes
- Apply a very thin layer only to affected areas. Limit therapy to 5 days if used on the face.
- Body Weight
- 16-20 kg
- Dose
- Not routine
- Frequency
- Once daily if prescribed
- Tracking Notes
- Monitor for systemic side effects if used on large body surface areas.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | Do not use | Safety and efficacy in infants under this weight have not been established; high risk of systemic steroid absorption. |
| 5-7 kg | Not routine | Use only if prescribed | Requires pediatric supervision. Apply the smallest effective amount to minimal surface areas for the shortest duration. |
| 8-10 kg | Not routine | Use only if prescribed | Avoid prolonged use, application to face, or diaper area under occlusion. |
| 11-15 kg | Not routine | Once daily if prescribed | Apply a very thin layer only to affected areas. Limit therapy to 5 days if used on the face. |
| 16-20 kg | Not routine | Once daily if prescribed | Monitor for systemic side effects if used on large body surface areas. |
Formulation
Purpose
Relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as eczema, psoriasis, and dermatitis, as well as the treatment of allergic rhinitis symptoms.
Generic Name
Mometasone FuroateScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.